Onco Nano Medicine Appoints Dr. Kartik Krishnan As Chief Executive Officer and Dr. Melissa Paoloni As Executive Vice President and Chief Operating Officer

Mar 01, 2024•almost 2 years ago

Position

Chief Executive Officer

Company

OncoNano Medicine

Kartik Krishnan

SouthlakeTherapeuticsMedicalBiotechnologyHealth Care

Description

OncoNano Medicine, Inc. announces the appointment of Dr. Kartik Krishnan, MD, PhD to Chief Executive Officer (CEO) and member of the Board of Directors, succeeding Martin Driscoll

Company Information

Company

OncoNano Medicine

Location

Southlake, Texas, United States

About

OncoNano Medicine is developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease. pH variability is a proven, simple and effective identifier of diseased tissue providing a foundation for the development of a broad range of highly targeted therapeutics and imaging agents. Our lead program, ONM-100, targets tumor acidosis to accurately differentiate cancer from healthy tissue for use in surgery.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Onco Nano Medicine Appoints Dr. Kartik Krishnan As Chief Executive Officer and Dr. Melissa Paoloni As Executive Vice President and Chief Operating Officer

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Executive Insights

Company Information